|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Rescula
Sucampo Founder and CEO Ryuji Ueno Receives Japan Innovator Award - Nov 29, 2006
Drug Newswire (press release),After leading the successful development and commercial launch of the glaucoma therapy RESCULA(R), Dr. Ueno and Sachiko Kuno, Ph.D., founded the Sucampo
S*BIO Appoints Joy Zhu Senior Vice President of Global Clinical ... Oct 27, 2006
...from Phase 1 to Phase 3. At Novartis, Dr. Zhu was responsible for two successful NDA submissions for ophthalmic drugs (Zaditor® and Rescula®), both approved ... -Yahoo! News (press release)
Sucampo Founder and CEO Ryuji Ueno Receives Japan Innovator Award - Nov 29, 2006
Drug Newswire (press release),After leading the successful development and commercial launch of the glaucoma therapy RESCULA(R), Dr. Ueno and Sachiko Kuno, Ph.D., founded the Sucampo
AMITIZA(TM) (Lubiprostone), the First Selective Chloride Channel ... Apr 25, 2006
The first commercial prostone product, RESCULA(R), was launched in Japan, and later in more than 40 countries, for the treatment of glaucoma. ... - International News Service
Novel mechanism of action of lubiprostone provides effective and ... Apr 25, 2006
The first commercial prostone product, RESCULA®, was launched in Japan, and later in more than 40 countries, for the treatment of glaucoma. ... - RxPG NEWS
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|